Debt-to-equity of Aura Biosciences, Inc. from 30 Jun 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Aura Biosciences, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2022 to 30 Sep 2025.
  • Aura Biosciences, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 20%, a 40% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Aura Biosciences, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 20% +5.7% +40% 30 Sep 2025
Q2 2025 19% +4.6% +33% 30 Jun 2025
Q1 2025 18% +3.3% +22% 31 Mar 2025
Q4 2024 16% +0.62% +4.1% 31 Dec 2024
Q3 2024 14% -1.5% -9.7% 30 Sep 2024
Q2 2024 14% -2.3% -14% 30 Jun 2024
Q1 2024 15% +0.37% +2.6% 31 Mar 2024
Q4 2023 15% +3.4% +30% 31 Dec 2023
Q3 2023 16% +6.9% +78% 30 Sep 2023
Q2 2023 17% +7.8% +89% 30 Jun 2023
Q1 2023 14% 31 Mar 2023
Q4 2022 12% 31 Dec 2022
Q3 2022 8.8% 30 Sep 2022
Q2 2022 8.7% 30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.